Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures
Ursula Heilmeier(University of California, San Francisco), Thomas M. Link(Quantitative BioSciences), Gabby B. Joseph(University of California, San Francisco), Thomas Lang(University of Bremen), Andrew J. Burghardt(University of California, San Francisco), Thomas Baum(University of California, San Francisco), Janina Patsch(Medical University of Vienna), Roy Harnish(University of California, San Francisco), D. R. Carpenter(University of Colorado Denver), Ann V. Schwartz(University of California, San Francisco)
Cited by 62
Related Papers
The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition Study
|The Journals of Gerontology Series A|2006|3k
Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures
|Journal of Bone and Mineral Research|2012|436
Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures
|Journal of Bone and Mineral Research|2013|324